Podcasts about medication management

In April Month in Review, we take a powerful look back at the conversations that shaped this month's episodes. In Episode 306, Don't Stay Stuck on What Sucks, we explore how negativity bias keeps us trapped in harmful mindsets and share practical strategies for shifting focus toward growth and healing. Episode 307, Medication Management with Carrie Hill, brings a compassionate perspective on psychiatric medication, addressing fears, debunking myths, and empowering listeners to take charge of their mental health journey. Finally, Episode 308, Is a One-Night Stand Worth It?, examines the motivations, insecurities, and societal perceptions surrounding casual sex, asking the deeper question: what does sex really mean to you? Candid, insightful, and deeply human in this month's conversations invite you to move forward with clarity and courage. Tune in to see the April Month in Review Through a Therapist's Eyes.  

In this episode, Dr. Brittany Schamerhorn discusses the role of GLP-1 receptor agonists in women's health, particularly focusing on their applications in managing diabetes, obesity, and conditions like PCOS and menopause.  This conversation also highlights: Risks and benefits associated with GLP-1s The complexities of managing medications and the importance of understanding medication tolerability How a holistic approach combining medication with lifestyle changes can achieve sustainable health outcomes The need for proper caloric intake to maintain metabolic health  Future applications of GLP-1 medications   Show Notes: Learn more about Dr. Schamerhorn and her upcoming webinar on GLP-1s and women's health. To explore how the DUTCH Test can profoundly change the lives of your patients, become a DUTCH Provider today! 

Medication management is taking a big role in health care today and at HIMSS for several reasons. More medications are coming on the market, providing impressively successful treatments for many conditions. More people of all ages are taking more medications. And specialty medications, which are very expensive, are also burgeoning.In this video, we hear some current expert perspectives on medication management, including the roles of automation and AI, from Dr. Michael Blackman, Chief Medical Officer at Greenway Health, and Dr. Colin Banas, Chief Medical Officer at DrFirst.Learn more about Greenway Health: https://www.greenwayhealth.com/Learn more about DrFirst: https://drfirst.com/Health IT Community: https://www.healthcareittoday.com/

In this episode we're joined by Carrie Hill, PMHNP-BC, CARN-AP—a seasoned psychiatric nurse practitioner with over 16 years of experience—to dive deep into the often misunderstood world of medication management in mental health care. Carrie shares her compassionate, patient-centered approach to treatment, blending personalized medication plans with therapy and holistic care for individuals aged 13 to 64. We tackle common fears about psychiatric medications, including public misconceptions and high-profile critiques, while exploring how open communication and ongoing assessment can lead to better outcomes. You will learn how combining therapy and medication can empower individuals on their mental health journey—and hear real-world success stories that show what's possible when care is tailored, collaborative, and rooted in empathy. Tune in to see Medication Management Through a Therapist's Eyes.  

Are you battling the weight of mental health challenges while raising your grandchildren? Do you feel the complexity of navigating a bipolar disorder diagnosis and its impact on your family, especially when relief seems out of reach? Are you searching for proven strategies to manage emotional turmoil and reclaim a sense of normalcy for your loved ones? Understanding and healing with bipolar disorder can feel like a never-ending rollercoaster, filled with peaks of mania and valleys of depression.I'm Laura Brazan, and today's episode of "Grandparents Raising Grandchildren: Nurturing Through Adversity" features an inspiring journey of resilience and recovery. Join us as we explore the story of Michelle Rettinger, who triumphed over the despair of bipolar disorder through a groundbreaking approach that focuses on empowerment and understanding. Diagnosed in 1998, Michelle endured years of turbulent emotions and extensive medical intervention. Yet, through personal responsibility and a commitment to an innovative treatment model, Michelle found a path to genuine healing.In this episode, Michelle, now a thriving public speaker, author, and mentor, shares her free resource, the Mood Cycle Survival Guide, which has been pivotal in her recovery. We'll delve into her integrated, research-backed treatment model that addresses the root causes of bipolar symptoms, offering hope and praSend us a textWould love to hear more of a 'deep dive" into the 4 skills. Owner, Broker, and Realtor at Team Eureka with National Parks Realty Forbes Global Properties—Sandi Hall is a beacon of trust and insight for both local and international clients. With a Graduate REALTOR® Institute designation and a feature in Forbes, underscore her commitment to excellence.Visit WelcomeHomeMontana.com today or call (406) 471-0749 and experience the difference an expert like Sandi can bring to your journey home. Big Heart Family Dentistry, led by Dr. Seth Hinckley. Their dedication goes beyond treating teeth; they empower healthier, happier lives through prevention and education. They use state-of-the-art technology and are deeply connected to the community, addressing every dental need with expertise and heart. Taking care of ourselves should be fun! Here's another self-care tip from Jeanette Yates!Thank you for tuning into today's episode. It's been a journey of shared stories, insights, and invaluable advice from the heart of a community that knows the beauty and challenges of raising grandchildren. Your presence and engagement mean the world to us and to grandparents everywhere stepping up in ways they never imagined. Remember, you're not alone on this journey. For more resources, support, and stories, visit our website and follow us on our social media channels. If today's episode moved you, consider sharing it with someone who might find comfort and connection in our shared experiences. We look forward to bringing more stories and expert advice your way next week. Until then, take care of yourselves and each other.Want to be a guest on Grandparents Raising Grandchildren: Nurturing Through Adversity? Send Laura Brazan a message on PodMatch, here: https://www.podmatch.com/hostdetailpreview/grgLiked this episode? Share it and tag us on Facebook @GrandparentsRaisingGrandchilden Love the show? Leave a review and let us know! CONNECT WITH US: Website | Facebook

In this episode of the Addict to Athlete podcast, Coach Blu Robinson engages with Dr. Mark Hrymoc, an addiction psychiatrist, to discuss the evolving landscape of addiction treatment, particularly focusing on Medication-Assisted Treatment (MAT). They explore the importance of integrating mental and physical health in recovery, the duration of care needed for individuals struggling with addiction, and the risks associated with rapid detoxification. Dr. Hrymoc explains how Suboxone works in the brain to help stabilize patients and addresses the mixed data surrounding cannabis as a treatment option. The conversation emphasizes the need for a compassionate, individualized approach to addiction recovery, highlighting the importance of destigmatizing medication use in treatment. In this conversation, Dr. Mark Hrymoc discusses the evolving landscape of psychiatric treatments, particularly focusing on psychedelics and ketamine. He emphasizes the importance of understanding co-occurring disorders and the psychological aspects of pain management. The discussion also touches on the future of non-addictive pain medications and the significance of building trust in treatment relationships. Dr. Hrymoc advocates for open communication between patients and healthcare providers to foster effective treatment outcomes.   Takeaways MAT offers a new perspective on addiction treatment. Combining medication and therapy yields the best results. Addiction is a chronic disease with no cure. Long-term relationships with clients are crucial for recovery. Rapid detox can be dangerous and should be approached with caution. Suboxone helps stabilize patients without the high of other opioids. Cannabis has mixed results in treating mental health issues. Destigmatizing medication-assisted treatment is essential. Every family has someone affected by addiction. Individualized treatment plans are key to successful recovery. Psychedelics are being researched for various psychiatric conditions. Ketamine is effective for treatment-resistant depression and anxiety. Understanding the timeline of addiction and mental health issues is crucial. Pain perception is influenced by both physical and psychological factors.   00:00- Introduction to Addiction and Recovery 01:55- Understanding Medication-Assisted Treatment (MAT) 07:28- The Intersection of Mental and Physical Health in Recovery 10:41- The Duration of Care in Addiction Recovery 14:28- The Risks of Rapid Detox and Medication Management 18:01- How Suboxone Works in Addiction Treatment 21:47- Exploring Harm Reduction and Future Treatment Trends 23:57- The Evolving Landscape of Psychedelics in Psychiatry 26:20- Ketamine as a Treatment for Depression 28:56- Navigating Co-Occurring Disorders 32:56- The Future of Non-Addictive Pain Medications 36:37- Understanding Pain: The Psychological Component 41:58- Building Trust in Treatment Relationships   Please join Addict to Athlete's Patreon support page and help us turn the mess of addiction into the message of sobriety! https://www.patreon.com/addicttoathlete Please visit our website for more information on Team Addict to Athlete and Addiction Recovery Podcasts. https://www.AddictToAthlete.org Join the Team! Circle, our new social support event, along with the team and athlete communication platform, is designed to help us break free from doom scrolling and shadow banning and foster stronger connections among us. Follow the link, download the app, and start this new chapter of Team AIIA! Join Circle https://a2a.circle.so/join?invitation_token=16daaa0d9ecd7421d384dd05a461464ce149cc9e-63d4aa30-1a67-4120-ae12-124791dfb519

In this episode, Brandi Mac interviews her daughter Brooke, who is now 15 months sober.  They discuss Brooke's journey through addiction, the impact of drug use on  family relationships and the challenges of medicated assisted treatment. The conversation highlights the importance of appropriate dosing in recovery, the emotional turmoil of addiction, and the lessons learned in healing and rebuilding relationships.      00:00 Introduction and Background on Sobriety 03:00 The Journey of Addiction: Drugs of Choice 05:17 Understanding Fentanyl: The Hidden Dangers 08:04 Impact of Drug Use on Family Relationships 11:02 The Struggles of Recovery and Healing 1 3:47 Medicated Assisted Treatment: A New Perspective 1 9:57 The Importance of Proper Dosing in Treatment 34:22 Navigating Detox and Medication Management 37:01 Experiences in Treatment Facilities 40:55 Therapeutic Approaches and Their Impact 45:50 Finding Connection Amidst Isolation 49:07 Challenges of Reintegration After Treatment 49:15 Lessons Learned in Sobriety 55:52 Supporting Loved Ones Struggling with Addiction   To contact Brandi Mac you can email: brandimac.creator@gmail.com

In this episode of "Next Steps 4 Seniors: Conversations on Aging," host Wendy Jones discusses the critical topic of medication management for aging adults. Wendy, along with an unnamed speaker, highlights the complexities and risks of managing multiple medications, including memory issues and pharmacy. They share real-life stories to illustrate the dangers of improper medication use and emphasize the importance of collaboration with healthcare providers. Wendy advises consulting pharmacists for potential drug interactions and maintaining updated medication records. The episode aims to provide practical tips to help families ensure the safety and well-being of their aging loved ones. Have questions or suggestions? Call 248-651-5010 or email hello@nextsteps4seniors.com. For podcast topics or sponsorship opportunities, contact marketing@nextsteps4seniors.com. Don’t forget to subscribe, follow, and share on your favorite podcast platform. Visit NextSteps4Seniors.com to learn more and explore additional resources. Let’s take the next steps together! This episode is proudly sponsored by Aeroflow Urology, a leader in incontinence care solutions. You may be eligible to receive your incontinence supplies at no cost through your insurance, delivered discreetly and directly to your door. *Some exclusions apply Visit aeroflowurology.com/ns4s to learn more and see if you're eligible.Learn more : https://nextsteps4seniors.com/See omnystudio.com/listener for privacy information.

In the podcast episode "Next Steps for Seniors," host Wendy Jones and guest Frank Dubois discuss GeneSight, a pharmacogenomic test aiding seniors in managing multiple medications. Wendy highlights the growing interest in GeneSight among nurse practitioners, while Frank explains the test's process and benefits. He shares a poignant story about a nursing home patient whose life improved significantly after switching medications based on GeneSight results. The episode underscores the importance of personalized medicine, advocating for GeneSight testing to optimize treatment plans and enhance seniors' quality of life. Wendy encourages listeners to explore this valuable resource for better medication management.Support our mission: https://nextsteps4seniors.com/See omnystudio.com/listener for privacy information.

In the episode of "Next Steps 4 Seniors: Conversations on Aging," host Wendy Jones and guest Erica Ancel, director of operations for Next Steps for Seniors, discuss strategies for seniors to maintain their independence. They cover essential safety tips like removing throw rugs and using safe kitchen utensils, the importance of hydration with alternatives to plain water, mobility exercises to maintain muscle mass and balance, and socialization strategies to combat isolation. The episode provides practical advice and resources to help seniors live independently and safely, enhancing their quality of life as they age. Support our mission: https://nextsteps4seniors.com/See omnystudio.com/listener for privacy information.

The NP sees  a 44-year-old male of African ancestry with a BMI=34 kg/m2 and recently diagnosed  type 2 diabetes mellitus. He works on a rotating shift in healthcare and reports eating irregularly. He was started on metformin therapy 4 months ago, is at maximum recommended dose, and states he is tolerating the medication well. His initial A1c was 9.8%, with today's A1c=8.7%. eGFR is within acceptable parameters and he is feeling well, stating, “I was so thirsty and needed to urinate all the time before I started that pill”. Physical exam reveals extensive acanthosis nigricans.  He mentions that his health insurance. “Does not pay for all that much. I'm OK with paying for the pill I am taking now, but really cannot afford expensive medicines. “ Which of the following is the most appropriate next step? A. Prescribe weekly injectable semaglutide.  B. Adding post-meal sliding scale rapid acting insulin.C. Add a daily dose of pioglitazone.D. Add glipizide on days when his eating schedule is predictable.  ---YouTube: https://www.youtube.com/watch?v=xyh0ld2l9_M&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=103Visit fhea.com to learn more!

TopMedTalk is at The American Society of Anesthesiologists (ASA)'s annual general meeting; Anesthesiology 2024. Here we discuss key anesthesia updates, emphasizing patient safety and comfort. Does the evidence support allowing clear liquids up to surgery to reduce thirst without raising risks? Do new challenges around GLP-1 drugs, which delay stomach emptying, call for tailored pre-op guidance? Also, should we be rethinking gabapentinoids, which recent studies show may not effectively reduce opioid use as once believed? Presented by Desiree Chappell, Monty Mythen and Mike Grocott with their guests, Girish P. Joshi, Professor, Anesthesiology and Pain Management at UT Southwestern Medical Center and Ben Gibbison, Associate Professor of Cardiac Anaesthesia and Intensive Care at the University of Bristol, Honorary Consultant at University Hospitals Bristol and Weston NHS Foundation Trust.

In this episode of "Next Steps 4 Seniors: Conversations on Aging," host Wendy Jones offers essential tips for family caregivers of elderly loved ones. Drawing from her healthcare experience, Wendy discusses the financial burdens of professional care, the importance of understanding medical diagnoses, and effective medication management. She emphasizes utilizing local resources, creating task lists, and holding family meetings to delegate responsibilities. Wendy also highlights the significance of support groups and recognizing signs of caregiver burnout. The episode aims to educate and support caregivers, reminding them they are not alone in their journey. Have questions or suggestions? Call 248-651-5010 or email hello@nextsteps4seniors.com. For podcast topics or sponsorship opportunities, contact marketing@nextsteps4seniors.com. Don’t forget to subscribe, follow, and share on your favorite podcast platform. Visit NextSteps4Seniors.com to learn more and explore additional resources. Let’s take the next steps together! This episode is proudly sponsored by Aeroflow Urology, a leader in incontinence care solutions. You may be eligible to receive your incontinence supplies at no cost through your insurance, delivered discreetly and directly to your door. Visit aeroflowurology.com/ns4s to learn more. Introduction to Family Caregiving (00:00:06)Wendy introduces the podcast and emphasizes the importance of supporting family caregivers. Understanding Medical Management (00:01:14)Discusses the significance of having the right doctor and understanding medical diagnoses and medications. Locating Local Resources (00:02:17)Encourages caregivers to find local resources and financial assistance available for elderly loved ones. Creating Two Lists (00:03:24)Advises caregivers to make lists of tasks they can and cannot do to better manage responsibilities. Engaging Family and Friends (00:03:24)Suggests holding a meeting with family and friends to delegate caregiving tasks effectively. Finding Support Groups (00:04:19)Stresses the importance of joining support groups for caregivers to share experiences and find help. Recognizing Caregiver Burnout (00:05:38)Identifies signs of caregiver burnout and the importance of seeking help when feeling overwhelmed. Exploring Available Options (00:06:42)Discusses various support options, including adult day centers and senior living communities for caregivers.Support our mission: https://nextsteps4seniors.com/See omnystudio.com/listener for privacy information.

Yoona Kim, CEO of Arine,  a medication intelligence company, works with health plans and payers to ensure safe and effective medication therapy for patients. The Arine platform addresses polypharmacy, medication mismanagement, drug interactions, and proper dosing. Using AI and integrated databases, Arine is identifying patients who would benefit from medication management and shifting from reactive to proactive and preventative care. Yoona explains, "Our clients are health plans and risk-bearing providers. So these are the payers of the healthcare system, those who bear the financial burden of healthcare costs because medications can be very powerful, they can cure, or they can lead to detrimental consequences and even unnecessary fatalities and high-cost events like hospitalizations. So it's important to these customers to make sure that their members are on the right medications to avoid these unnecessary clinical and financial outcomes."  "I think it pertains to all of these situations. One of our biggest problems in healthcare is that 66% of Americans are on some prescription drugs, and in fact, more than 50% use more than three drugs a year. We need to search through a population and find who would benefit from a medication change with the population-based approach. This is why we spent so much time at Arine building our patient targeting model to identify in which patients would a small medication change lead to a difference in outcomes." "We're looking through all that patient's data, their medication history, their medical history, their demographics, and what their current clinical social, and behavioral risk factors are so we can identify that they're on the best medications, the safest and most effective for where they are in their health trajectory today. And, of course, the challenge is that their patient evolving health needs constantly change over time. On top of that, we have new medications being approved constantly and new advances being made. Our platform puts all this information together so that we can ensure that the best medication regimen is prescribed to the patients." #Arine #Medication #MedicationManagement #MedicationMismanagement #Prescription #SDOH #ArtificialIntelligence #Polypharmacy #Deprescribing #Overprescribing  #MedicationAdherence Arine.io Download the transcript here

Yoona Kim, CEO of Arine,  a medication intelligence company, works with health plans and payers to ensure safe and effective medication therapy for patients. The Arine platform addresses polypharmacy, medication mismanagement, drug interactions, and proper dosing. Using AI and integrated databases, Arine is identifying patients who would benefit from medication management and shifting from reactive to proactive and preventative care. Yoona explains, "Our clients are health plans and risk-bearing providers. So these are the payers of the healthcare system, those who bear the financial burden of healthcare costs because medications can be very powerful, they can cure, or they can lead to detrimental consequences and even unnecessary fatalities and high-cost events like hospitalizations. So it's important to these customers to make sure that their members are on the right medications to avoid these unnecessary clinical and financial outcomes."  "I think it pertains to all of these situations. One of our biggest problems in healthcare is that 66% of Americans are on some prescription drugs, and in fact, more than 50% use more than three drugs a year. We need to search through a population and find who would benefit from a medication change with the population-based approach. This is why we spent so much time at Arine building our patient targeting model to identify in which patients would a small medication change lead to a difference in outcomes." "We're looking through all that patient's data, their medication history, their medical history, their demographics, and what their current clinical social, and behavioral risk factors are so we can identify that they're on the best medications, the safest and most effective for where they are in their health trajectory today. And, of course, the challenge is that their patient evolving health needs constantly change over time. On top of that, we have new medications being approved constantly and new advances being made. Our platform puts all this information together so that we can ensure that the best medication regimen is prescribed to the patients." #Arine #Medication #MedicationManagement #MedicationMismanagement #Prescription #SDOH #ArtificialIntelligence #Polypharmacy #Deprescribing #Overprescribing  #MedicationAdherence Arine.io Listen to the podcast here

Dr. Benjamen Morrell, M.D. is an integrative psychiatrist.  He has his own clinic, the LIT Clinic where he focuses on enhancing brain health, lifestyle, & performance by using natural alternatives to medications.  He specializes in: Psychiatry & Psychotherapy Natural alternatives to medications Medication Management & DiscontinuationHolistic & Individualized Health ProgramsPsychology: Motivation, Focus, PurposeKetamine-Assisted PsychotherapyHe is also the host of LIT CLINIC Podcast on Spotify where he hosts guests from all walks of life to share wisdom and free resources on mental health.You can find out about his clinic at:www.litclinic.comButcherbox:http://butcherbox.pxf.io/vNXyWA

October 23, 2024: Weston Blakeslee, VP of Population Health at DrFirst, to explore the intersection of medication management, population health, and artificial intelligence. Can medication adherence be improved through predictive models and smart technologies like pill bottle caps? Blakeslee explains DrFirst's role in bridging the gap between hospital visits and medication adherence, tackling long-standing data quality issues, and exploring innovative solutions in population health. Key Points:02:08 Medication Adherence and Population Health08:34 Innovative Solutions for Medication Tracking10:18 AI in Medication Management12:16 Future of Population HealthSubscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Dhineli Perera talks to complex care coordinator Deirdre Criddle and senior pharmacist Rohan Elliott about their paper on safe medication management during transitions of care from hospital. They cover the potential hazards that arise during transitions of care, available services, and the need for a stewardship framework for managing hospital transitions. Read the full paper by Deirdre, Rohan, and their co-authors, in Australian Prescriber.

Dave & Scott battle it out, debating which oral steroid is the best TIME STAMPS BELOW 00:00:00 Introduction to the Podcast 00:03:41 Anadrol Application and Limitations 00:06:43 Dbol: A Classic Muscle Builder's Challenges and Benefits 00:09:50 Benefits and Misconceptions of Anavar and T-Bol 00:13:19 Anadrol & Dbol Cycle Insights 00:16:41 Dave's Squirrel Picnic table 00:18:30 Less Gear For Longer Or More For Shorter Cycles? 00:20:04 Super High Intensity Cycles - SHIC Approach 00:21:30 First Cycle: Lessons and Reflections 00:26:31 Understanding Drug Effects Based on Body Composition 00:28:30 Jordan Peters Using Halotestin Preworkout 00:32:57 JP: A Unique Approach to Bodybuilding 00:36:54 Dry Carb Loading Strategy 00:39:49 Managing Prolactin Levels During Cycles 00:43:38 Impact of Test Suspension on Estrogen Levels 00:44:50 T4 Stand Alone For Fat Burning 00:46:36 Low Test with High Tren or High Test with Low Tren 00:48:20 Effects of Long-Term EQ Use and Health Implications 00:53:00 Fast Drug Metabolism and Medication Management 00:55:59 T Shirt Contest 00:57:45 Uncle Dave's Advice : The Value of Giving Without Expectation 01:02:21 PED Course and Pillars Explained 01:04:48 Supplements for Your Dog's Joint Health at Strom

Sept. 10, 2024 - Assemblymember John McDonald, a Capital Region Democrat and practicing pharmacist, discusses an effort spearheaded by state regulators to create standardized, all-encompassing oversight of an evolving trend in pharmacies.

www.YourHealth.orgwww.SCHomeRx.comwww.thedisruptedpodcast.comwww.experiencinghealthcare.com

If you're mother or father is at a point where they need help with tasks like showering or dressing, you should call one of the elderly care experts at More-Time Healthcare Limited (01375 503102) in Thurrock, Essex. Go to https://www.moretimehealthcare.com to find out more. More-Time Healthcare Limited City: Tilbury Address: 6A Calcutta Road, Website: https://www.moretimehealthcare.com/

This episode of Better Edge delves into the challenges of medication management for individuals with mild cognitive impairment and dementia. Rachel O'Conor, PhD, MD, associate professor of Geriatrics at Northwestern Medicine, and a health services and public health researcher specializing in community-engaged research, shares insights from a recent study involving patients and their caregivers. The discussion highlights the difficulties faced by those with changing cognitive abilities in managing multi-drug regimens and the crucial role of family members in this process. Dr. O'Conor emphasizes the importance of understanding both patient and caregiver perspectives to navigate these challenges effectively.

Panelists: Brian Norton, Belva Smith, Josh Anderson Q1. Medication Management, Q2. Communication solutions, Q3. PDF Reader for iOS, Q4. Wildcard: Favorite iOS18 Accessibility Feature   —– Transcript Starts Here —– Speaker 1: I have a question. Huh? Like what? I’ve always wondered… What about… Do you know… I have a question. I’ve always wondered… Like, […] The post ATFAQ192 – Q1. Medication Management, Q2. ASL Interpreting, Q3. PDF Reader for iOS, Q4. Wildcard: Favorite iOS18 Accessibility Feature first appeared on Assistive Technology at Easter Seals Crossroads.

Send us a Text Message.Welcome back to another fabulous episode of the Healthcare Trailblazers podcast! Today, we're joined by the wonderful Ariel Efergan, the Global Vice President of MDI Health. Ariel delves into the transformative work MDI Health is doing to tackle one of the leading causes of death in healthcare: problems from medication treatment. Discover how MDI Health uses AI for medication management at scale, reducing the total cost of care and driving clinical interventions. Ariel also shares insights on navigating healthcare sales, the importance of understanding healthcare's financial flow, and the future of AI in healthcare.Key Takeaways:MDI Health's Mission: Using AI to manage medication treatment, reducing costs, and improving patient outcomes.AI's Role: Automates and enhances clinical recommendations, scaling pharmacist interventions.Healthcare Sales Challenges: Importance of understanding organizational needs, relationships, and financial flows.Future of AI in Healthcare: Emphasis on AI as a co-pilot, focusing on tangible outcomes rather than technology alone.MDI Health's Success: Significant cost savings and improved patient outcomes through AI-driven pharmacy interventions.

In this episode, the team from the Henry Ford Health System to discuss their award winning submission to the ASHP Best Practices.  They will share how the addition of a pharmacist to the multidisciplinary interstitial lung disease (ILD) team, along with the robust collaboration with a specialty pharmacy, improved the quality of patient care in ILD and generated significant revenue for their health system. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Michelle Keller is an assistant professor of gerontology and the Leonard and Sophie Davis Early Career Chair in Minority Aging at the USC Leonard Davis School. She spoke to us about her research focused on improving patient-clinician communication, medication management, and the identification of dementia in minority older adults. Here are highlights from our conversation. On polypharmacy “When it comes to older adults and medications, it's important to understand that while medications can be incredibly beneficial for treating various conditions, they can also present really unique risks in this population. Older adults often take multiple medications at the same time. This is what we call polypharmacy.” “Older adults can be more sensitive to certain medications, they might experience side effects more intensely or even at lower doses than younger individuals. … This is particularly true for medications that affect our central nervous system, our brain, right? So, thinking about medications that are sedating or that have some sort of psychoactive effect. These medications, especially when they're combined together, can lead to things like confusion, dizziness and an increased risk of falls.” On her study of interventions to address polypharmacy “What we found in this study was that interventions to address polypharmacy can do a great job of reducing medications which are potentially harmful, identifying which medications people should be taking, improving the appropriateness of the medications people are taking, and reducing the total number of medications. So thinking about outcomes related to medications, what we have found is that it is really hard to change more downstream clinical outcomes, things like mortality, falls, hospitalizations, and emergency department visits. We did find that interventions that had multiple components; in other words, where a clinician is meeting face to face with a patient, reviewing their medications, reviewing all the chronic diseases that they have, along with their full patient history of what has happened to them in the past, those interventions tend to have a greater effect on mortality. So in other words, those types of interventions are reducing the risk of that someone actually dies.” “We also found that falls decrease when patients fully stop potentially harmful medications. These may be medications where somebody is feeling very dizzy or that make people feel very dizzy or drowsy, medications that may control somebody's blood sugar a little bit too much… So, their blood pressure's a little too low and they may actually fall as a result of these medications. But what we found was that stopping medications such as benzodiazepines, which are often taken for sleep or anxiety, can take months. These types of medications can have withdrawal effects. And so it's really, really important for somebody to work very closely with a healthcare provider to slowly taper these medications down to try to reduce those withdrawal effects.” “What we have found in working with other researchers and clinicians is that when patients team up with a healthcare provider, such as their primary care physician or clinical pharmacist who's embedded in the healthcare system, they really are able to stop taking some of these medications, and they feel a lot better. They feel much more energy, they're able to do the things that they really enjoy. They have a greater quality of life. But it's something that just takes time.” On the Empower Intervention for benzodiazepines “The typical recommendation for benzodiazepines is that they really should be taken short-term. These are medications that physicians typically recommend somebody take for a maximum of four weeks. What we have found in some of our research is that people are actually taking these for years, if not decades. And so stopping these medications can be quite challenging, and sometimes patients aren't fully convinced about why they should be stopping these medications. So, we took an intervention that started in Canada. It was developed by researchers in Quebec, and this is called the Empower Intervention. And what we did is we tailored it to a health system here in the US. The Empower Intervention is a really great brochure that contains some pretty striking facts about benzodiazepines.” “To give you some examples of benzodiazepine, these are like your Xanax, your Ativan, your Klonopin; these are the medications that we're talking about here. These brochures highlighted some really interesting facts, such as the fact that they can be harmful or linked to hip fractures and car accidents, and they can make people feel very tired and weak. What we did for this intervention is we sent these brochures to about 300 people along with a letter from their primary care physician, emphasizing that these medications can be harmful if taken for too long and especially among older adults. So what we did for this study is we compared patients who had received these brochures to patients who did not receive them. So they're going on usual care. Their physicians may have mentioned something to them, this was our control group, right? We didn't send anything to this particular group.” “We reviewed the medical records for both groups, and we looked at what kinds of medications they had been prescribed. And what we found is that patients who received the brochures were really activated. You know, when they received this messaging they would send messages in the patient portal to their physicians saying, ‘I didn't know that there were these risks of these medications. I would really like to come in and talk to you about them.' They made appointments to start tapering down these medications. What we found was for every 10 brochures that we sent, one person completely stopped taking these medications, which is a really good return on investment. This is a simple intervention. It has now been done in some other health systems in the US, particularly the Veterans Affairs health system.” On challenges in de-prescribing “I think some of the challenges that physicians face in de-prescribing is that de-prescribing takes a lot of time. As we all know, our primary care visits are very short; physicians, particularly in the primary care setting, are really rushed through their visits. And so I think having some of these conversations can just be something that's challenging. I also think they're quite complex conversations to have. They may not have received the training, for example, on how to taper a medication in a safe way so that a patient does not feel withdrawal effects. And I do think that there is something about getting physician buy-in … they are concerned [that] if they bring it up, the patient may be angry with them; they may be upset. And so I think really showing physicians ways in which this can be brought up that are really framed around ‘how do we center the patient's health and quality of life' – I think those are still questions that we as researchers are working on.” On the role of caregivers “It's really important for caregivers to be aware of the medications their loved ones are taking for many reasons. I think they can be amazing advocates in helping bring up potential side effects during doctor's visits. So, for example, if a caregiver is noticing that someone is feeling drowsy or doesn't have that much energy or is feeling dizzy, any sort of cognitive impairments such as those that may be seen in dementia, [they] may actually be a result of medication side effects. So, I think really becoming an advocate for somebody when seeing the doctor is one really important thing that caregivers can do.”  “Another area where caregivers can play a really important role is among people with dementia. People with dementia can have really some challenges in managing their medications. They may miss doses, they may take several medications twice, so they may have an overdose, or they may take the wrong medication altogether. So, caregivers can play really pivotal roles in helping somebody manage medication changes. There have been some early interventions looking at how to engage caregivers and persons with dementia. And some of the challenges that those researchers have seen is that there [is] often more than one person actually caring for somebody with dementia. And so, engaging that whole group of people who may be working with that person has been a real challenge.” On challenges facing patients with language barriers  “There is research showing that patients with language barriers have a greater risk of being hospitalized or re-hospitalized because of some of the communication challenges that come with medication management. So, you can imagine that, for example, older adults and their caregivers with language barriers may have a difficult time understanding medication instructions, which can lead to improper use. So when and how to take medications, recognizing potential side effects, understanding the purpose of each medication. And on top of that, you can layer on things, like if somebody doesn't have a great understanding of the condition. We call that disease literacy, or they may have health literacy issues.” “Right now, a mentee and I are working on this review of interventions that have been done specifically for patients with language barriers focused on improving medication management. And what we found was that interventions that really engaged people from communities with language barriers have been some of the most effective ways to really help people learn about which medications are working really well for them, how to improve medication adherence and other important outcomes. So, for example, an intervention that we found was researchers engaged folks in the community, co-created videos about medications in the community and why it was important to take them. And then when they actually distributed these interventions, they made sure that both in terms of the videos and some of the other educational materials that were handed out to folks that these really were very tailored both language-wise, literacy-wise, and culturally tailored to the communities that they were serving.” On new dementia medications and disparities in the diagnosis of dementia  “We are learning that older Black and Latino adults tend to get diagnosed with dementia once the disease has progressed more. And what that means is that they may not have received some of the kind of services that may help them or their families. So, for example, they may not have received enough support to be able to plan for the rest of their lives, or their families may not necessarily have received caregiving support early on in disease progress.” “I think in regard to these particular dementia medications, for example, if older adults are diagnosed with dementia at a place where they're no longer eligible to receive these medications, I think that'll be a really pretty serious health equity issue. So, I am really interested in how we make sure that people are getting diagnosed in time to make them eligible for really potentially beneficial treatments that may help them down the road.” On effective strategies for de-prescribing  “The most effective strategies that we see de-prescribing these medications is offering something else. So, for example, some of the most evidence for insomnia really exists around the use of using cognitive behavioral therapy. There's also been well-done systematic reviews that have found evidence that music or acupuncture may help people with insomnia. … I think one thing that's very important to think about when we de-prescribe medications is what else can we offer people? We're not just leaving people in the lurch and saying, ‘We're taking this away and we're leaving you with nothing.' We're actually able to offer them some non-pharmacological options as well.” Transcript Speaker 1 (00:02): One thing that's very important to think about when we de-prescribe medications is: what else can we offer people? We're not just leaving people in the lurch and saying, we're taking this away and we're leaving you with nothing. We're actually able to offer them some non-pharmacological options as well Speaker 2 (00:17): From the USC Leonard Davis School of Gerontology, this is Lessons in Lifespan Health, a podcast about the science and scientists improving how we live and age. I'm Orli Belman, Chief Communications Officer. On today's episode: how Professor Michelle Keller is working with older adults, caregivers and clinicians to manage the use and potential overuse of high risk medications. Michelle Keller is an Assistant Professor of Gerontology and the Leonard and Sophie Davis Early Career Chair in Minority Aging at the USC Leonard Davis School. Her research is focused on improving patient-clinician communication, medication management, and the identification of dementia in minority older adults. Hi, Michelle. Welcome and thank you for joining us today. Speaker 1 (01:06): Thank you so much for having me. Speaker 2 (01:08): I wanna start by asking you to talk about older adults and medications. We can all understand why medications are beneficial, but when it comes to older adults, what are some of the ways they can be problematic? Speaker 1 (01:19): Absolutely. So when it comes to older adults and medications, it's important to understand that while medications can be incredibly beneficial for treating various conditions, they can also present really unique risks in this population. So older adults often take multiple medications at the same time. This is what we call polypharmacy. Polypharmacy can increase the risk of drug interactions, right? So I like to think of the example of a suitcase, right? So imagine that you are packing up, getting ready to go to a trip. You start putting one thing into the suitcase, gets a little heavy, but you can manage it, right? You're suddenly adding more and more things and the suitcase is getting heavier and heavier to the point where you actually throw out your back at the airport, right? This is really what I think of when our bodies are kind of processing multiple medications at once with the additional challenge that some of these drugs may actually interact with one another. Speaker 1 (02:15): This is why it's so important for patients to talk to their doctors about the medications they're taking and the potential risks of each medication as people get older. I think one thing that people don't often think about is that when clinical trials are being done, often many clinical trials have excluded older adults. So we don't always have a great sense of how these medications work in older adult populations. And on top of that, they may exclude people with chronic conditions who are already taking a variety of other medications. And so as a result, what is happening now is that we have many people who are taking these medications, and it hasn't been well tested in these populations. It hasn't really been, you know, we don't have a clear sense of what is happening when all of these medications are being taken together. So polypharmacy can really increase the risk of drug interactions. Speaker 1 (03:09): As I was saying, when one medication affects another, and this can lead to a variety of adverse effects. So for example, if someone is taking multiple medications that make you feel drowsy or sleepy when you stack them on top of each other–thinking again about that suitcase, that can lead someone to have an increased risk of falls, potentially a fracture resulting from those falls, car accidents if they're feeling very drowsy or dizzy and other medications can increase our risk of internal bleeding. Another thing that's really important to think about for older adults is that as we get older, our bodies undergo various changes that can alter how our medications are absorbed, distributed, and actually excreted from the body. So for example, kidney and liver function can really decline with age. And so that can actually affect how well we process the drugs through our body. Speaker 1 (04:05): What that means is that drugs may stay in our bodies for longer periods of time leading to more side effects or adverse effects. The last thing I really wanted to bring up is this idea of how things change as we get older. So we maybe have been taking a medication for many years, but as we get older because of the changes that are happening within our body, some medications, which were fine for us when we were younger, are now gonna lead to more serious adverse effects now that we're older. So older adults can be more sensitive to certain medications, so they might experience side effects more intensely or even at lower doses than younger individuals. They might feel the effects. So this is particularly true for medications that affect our central nervous system, our brain, right? So thinking about medications that are sedating or that have some sort of psychoactive effect. Speaker 1 (05:04): These medications, especially when they're combined together, can lead to things like confusion, dizziness, and an increased risk of falls. One medication which people often take to help them sleep is Benadryl or Tylenol PM. This medication is actually a drug that's really recommended to avoid in older adults because it can be very sedating, making people feel very drowsy throughout the day. And it actually also has the effects on the brain and has been associated with a higher increased risk of dementia. So these are medications that again, we don't think of as generally harmful, but again, in an older person might really be an issue. Speaker 2 (05:46): That's a really helpful example 'cause that's just an over the counter medication that anyone can get, even without a doctor. You recently published two papers looking at interventions for addressing polypharmacy. The first one was a review of several studies. What did you learn in that review about the effectiveness or not of programs that are designed to reduce harmful polypharmacy? Speaker 1 (06:08): So we reviewed several systematic reviews. These are collections, as you mentioned, of numerous studies to understand how well interventions to address polypharmacy are working. Many of these interventions include a process called de-prescribing, which is the process of systematically reducing or stopping medications that may no longer be beneficial or might be causing harm, particularly in older adults. The goal of deprescribing is to optimize an individual's medication regimen to improve their overall health and quality of life. What we found in this study was that interventions to address polypharmacy can do a great job of reducing medications which are potentially harmful, identifying which medications people should be taking, improving the appropriateness of the medications people are taking, and reducing the total number of medications. So thinking about outcomes related to medications, what we have found is that it is really hard to change more downstream clinical outcomes. Speaker 1 (07:11): Things like mortality falls, hospitalizations, and emergency department visits. We did find that interventions that had multiple components, in other words where a clinician is meeting face-to-face with a patient, reviewing their medications, reviewing all the chronic diseases that they have along with their full patient history of what has happened to them in the past, those interventions tend to have a greater effect on mortality. So in other words, those types of interventions are reducing the risk that someone actually dies. We also found that falls decrease when patients fully stop potentially harmful medications. So these may be medications that make people feel very dizzy or drowsy medications that may control somebody's blood sugar a little bit too much and so they're actually feeling very low blood sugar or medications where their blood pressure is overly controlled. So their blood pressure's a little too low, and they may actually fall as a result of these medications. Speaker 1 (08:12): But what we found was that stopping medications such as benzodiazepines, which are often taken for sleep or anxiety, can take months. These types of medications can have withdrawal effects. And so it's really, really important for somebody to work very closely with a healthcare provider to slowly taper these medications down, to try to reduce those withdrawal effects. And because it takes so long to fully stop these medications, it's hard for studies to really find an effect unless they're following that person for a long period of time, which studies often don't. And so that's one of the challenges that we've seen in the research is that studies haven't followed people for enough time. Or at the time that they're measuring some of these clinical outcomes, not enough time has gone by to really see the full effects. So what we have found in working with other researchers and clinicians is that when patients team up with a healthcare provider such as their primary care physician or clinical pharmacist who's embedded in the healthcare system, they really are able to stop taking some of these medications and they feel a lot better. They feel much more energy, they're able to do the things that they really enjoy. They have a greater quality of life, but it's something that just takes time. Speaker 2 (09:28): And I imagine it's something you have to balance when someone really might need a medication to treat something and then managing the side effects. That's really interesting. I know the second study looked at a particular intervention and this was the use of educational materials for benzodiazepines. What led you to explore this area and what did you find? Speaker 1 (09:49): Great question. So benzodiazepines are, as I mentioned earlier, medications that are often used for sleep or anxiety. The typical recommendation for benzodiazepines is that they really should be taken short term. These are medications that, you know, physicians typically recommend somebody take for a maximum of four weeks. What we have found in some of our research is that people are actually taking these for years, if not decades. And so stopping these medications can be quite challenging and sometimes patients aren't fully convinced about why they should be stopping these medications. So we took an intervention that started in Canada. It was developed by researchers in Canada, in Quebec, and this is called the Empower Intervention. And what we did is we tailored it to a health system here in the US. The Empower Intervention is a really great brochure that contains some pretty striking facts about benzodiazepines. Speaker 1 (10:45): To give you some examples of benzodiazepine, these are like your Xanax, your Ativan, your Klonopin. These are the medications that we're talking about here. These brochures highlighted some really interesting facts such as the fact that they can be harmful or linked to hip fractures and car accidents and they can make people feel very tired and weak. What we did for this intervention is we sent these brochures to about 300 people along with a letter from their primary care physician, emphasizing that these medications can be harmful if taken for too long and especially among older adults. So what we did for this study is we compared patients who had received these brochures to patients who did not receive them. So kind of they're going on their usual care, their physicians may have mentioned something to them. This was our control group, right? We didn't send anything to this particular group. Speaker 1 (11:40): We reviewed the medical records for both groups and we looked at what kinds of medications they had been prescribed. And what we found is that patients who received the brochures were really activated. You know, when they received this messaging, they would send messages in the patient portal to their physicians saying, I didn't know that there were these risks of these medications. I would really like to come in and talk to you about them. They made appointments to start tapering down these medications. What we found was for every 10 brochures that we sent, one person completely stopped taking these medications, which is a really good return on investment. This is a simple intervention. It has now been done in some other health systems in the US, particularly the Veterans Affairs health system. And you know, groups have found similar effects. We also found that the probability that someone in the intervention group completely stopped their medications was about 10% greater compared to the group that did not get the brochure. Speaker 1 (12:41): So again, you know, for a cheap simple intervention, we were pretty excited about these results. What's been really interesting is I just came back from two conferences, the US De-Prescribing Research Network and the Society for General Internal Medicine Annual Meeting. And we find that other researchers are also finding that engaging patients in reducing these potentially harmful medications is actually one of the most effective forms of deprescribing. There have been plenty of studies where researchers have actually engaged physicians and those have not been as successful. So what I'm really excited about in terms of thinking about future interventions is, how do we really engage patients in learning about what are the best options for them to manage their health? Speaker 2 (13:28): So you just said that physicians, it's been a little harder to see change in their prescribing behaviors. What do we know about ways they can introduce the idea of reducing or stopping a medication? Speaker 1 (13:39): Yeah, I think it's a great question. I think communicating when, how and why a medication should be reduced or stopped can be really challenging. What researchers have found is that when physicians focus on improving a patient's quality of life, that is what is most effective. So for example, thinking about stopping or reducing certain medications can give somebody more energy, help them move around better, they're not feeling as unsteady on their feet or dizzy. They can think more clearly because they're no longer feeling feelings of brain fog or sleepiness or drowsiness. I think these can be some really effective messages. I think some of the challenges that physicians face in de-prescribing is that de-prescribing takes a lot of time. As we all know, our primary care visits are very short. Physicians, particularly in the primary care setting, are really rushed through their visits. And so I think having some of these conversations can just be something that's challenging. Speaker 1 (14:41): I also think they're quite complex conversations to have. They may not have received the training, for example, on how to taper a medication in a safe way so that a patient does not feel withdrawal effects. And I do think that there is something about getting physician buy-in, in terms of, they are concerned about, you know, if they bring it up, the patient may be angry with them, they may be upset. And so I think really showing physicians ways in which this can be brought up that's really framed around, how do we center the patient's health and quality of life? I think those are are still questions that we as researchers are working on. Speaker 2 (15:17): We've talked about physicians and obviously patients themselves. How about caregivers? What role can they play in helping address some of these issues? And are there interventions that especially aim to include them? Speaker 1 (15:28): Yeah, great question. I think it's really important for caregivers to be aware of the medications their loved ones are taking. For many reasons. I think they can be amazing advocates in helping bring up potential side effects during doctor's visits. So for example, if a caregiver is noticing that someone is feeling drowsy or doesn't have that much energy or is feeling dizzy, any sort of cognitive impairments, right? So, such as those that may be seen in dementia, may actually be a result of medication side effects. So I think really becoming an advocate for somebody when seeing the doctor is one really important thing that caregivers can do. Another area where caregivers can play a really important role is among people with dementia. People with dementia can have some challenges in managing their medications. They may miss doses, they may take several medications twice, so they may have an overdose or they may take the wrong medication altogether. So caregivers can play really pivotal roles in helping somebody manage medication changes. There have been some early interventions looking at how to engage caregivers and persons with dementia. And some of the challenges that those researchers have seen is that there are often more than one person actually caring for somebody with dementia. And so engaging that whole group of people who may be working with that person has been a real challenge. Speaker 2 (16:54): Are there particular challenges faciing under-resourced communities or populations with language barriers? I imagine some of this communication is even harder in these cases. What do you think needs to be done in these areas? Speaker 1 (17:09): Absolutely. There is research showing that patients with language barriers have a greater risk of being hospitalized or rehospitalized because of some of the communication challenges that come with medication management. So you can imagine that for example, you know, older adults and their caregivers with language barriers may have a difficult time understanding medication instructions, which can lead to improper use. So when and how to take medications, recognizing potential side effects, understanding the purpose of each medication. And on top of that, you can layer on things like, you know, if somebody doesn't have a great understanding of the condition, right? So we call that disease literacy. Or they may have health literacy issues, or on top of that, we may even have literacy concerns where the person does not know how to read or has a limited ability to read. So layering on all these challenges can really make it difficult to both manage your medications and communicate with physicians about their concerns or side effects regarding medications. Speaker 1 (18:14): Right now, mentee and I are working on this review of interventions that have been done specifically for patients with language barriers focused on improving medication management. And what we found was that interventions that really engaged people from communities with language barriers have been some of the most effective ways to really help people learn about which medications are working really well for them, how to improve medication adherence and other important outcomes. So for example, an intervention that we found was researchers engaged folks in the community. They co-created videos about medications in the community and why it was important to take them. And then when they actually distributed these interventions, they made sure that both in terms of the videos and some of the other educational materials that were handed out to folks, that these really were very tailored both language wise, literacy wise, and culturally tailored to the communities that they were serving. Speaker 2 (19:16): Another area I wanna touch on is your work improving doctor patient communication. And I'm curious if your background as a newspaper reporter has informed your research in this area, and what are some of the ways that patients lose out when communication is not clear? Speaker 1 (19:32): So I think a lot about how we can help clinicians communicate complex information about medications and other treatments in simple, accessible ways. Which is really something that I aimed to do as a reporter, right? When I worked as a reporter, oftentimes I would take studies from medical journals and I would break them down in a way that was really easy and accessible for the public to read. And so that is really something that I'm very interested in. How do we help clinicians do the same thing? Or if we're designing interventions for patients, how do we do something similar? How do we make the risks and benefits of medications very clear to people so that they're able to make the best decisions about those for their health? So one area that I'm really interested in is these new medications for dementia that have come out, which are the anti amyloid medications. These medications have some pretty potentially serious side effects such as brain bleeding and swelling. And I'm working on a research proposal thinking about, how do we best present these medications to patients in a way that they feel like they're able to make the best decisions for themselves and their loved ones? I think it'd be really critical, particularly in terms of health equity for people to have a very good sense of how these medications can potentially help but also understand the serious risks associated with the new dementia medications. Speaker 2 (21:02): And speaking of dementia, I think you've also looked at the diagnosis of dementia and whether or not there's differences in minority populations. Is that something you can tell us a little bit about? Speaker 1 (21:14): Absolutely. So that is an area of research that I'm actually just starting to get into because what we are learning is that older black and Latino adults tend to get diagnosed with dementia once the disease has progressed more. And what that means is that they may not have received some of the services that may help them or their families. So for example, they may not have received enough support to be able to plan for the rest of their lives, or their families may not necessarily have received caregiving support early on in disease progress. I think in regards to these particular dementia medications, for example, if older adults are diagnosed with dementia at a place where they're no longer eligible to receive these medications, I think that'll be a really pretty serious health equity issue. So I am really interested in, how do we make sure that people are getting diagnosed in time to make them eligible for really potentially beneficial treatments that may help them down the road? So I'm thinking about how do we train physicians who are working in under-resourced settings, which may serve large proportions of black and Latino older adults, how to diagnose dementia in a primary care setting, and working with some colleagues in the Los Angeles Department of Health Services on how we can think about making physicians feel more confident, their diagnosis of dementia among older adults. Speaker 2 (22:40): And I wanna go back to sleep and anxiety because I know that's something that affects so many people at all ages. If these interventions are successful and people are able to stop taking some of these medications, are there strategies or interventions that we know might work for helping them with the initial conditions they were struggling with to begin with? Speaker 1 (23:01): Yeah, absolutely. I think that's a really good question because sleep and anxiety are things that can really affect somebody's quality of life and functioning, right? The most effective strategies that we see de-prescribing these medications is offering something else. So for example, some of the most evidence for insomnia really exists around using cognitive behavioral therapy. There's also been really well done systematic reviews that have found evidence that music or acupuncture may help people with insomnia. So I think one thing that's very important to think about when we de-prescribe medications is what else can we offer people? We're not just leaving people in the lurch and saying, we're taking this away and we're leaving you with nothing. We're actually able to offer them some non-pharmacological options as well. Speaker 2 (23:48): That's a really helpful note to end on. Thank you for joining us, and I know that people are really gonna benefit from learning about all you've been working on and all your work that's gonna continue in the future. Speaker 1 (23:59): Thank you so much for having me today. It's been a real pleasure. Speaker 2 (24:02): That wraps up this lesson in Lifespan Health. Thanks to Professor Michelle Keller for her time and expertise and to all of you for choosing to listen. Join us next time for another Lesson in Lifespan Health, and please subscribe to our podcast@lifespanhealth.usc.edu. Lessons in Lifespan Health is supported by the Ney Center for Healthspan Science.

Have you been unsure about getting an ADHD diagnosis? In this episode, host Lacey Estelle shares her personal journey of seeking an ADHD diagnosis, emphasizing the impact on one's quality of life. She discusses the avenues for obtaining a diagnosis, including consultations with healthcare professionals and specialized testing. Lacey explores the emotional aspects of seeking a diagnosis, addresses the benefits of clarity and tailored support, and provides insights into the diagnostic testing process and medication management for ADHD. Her compassionate approach creates a supportive space for listeners to navigate their own path towards self-discovery and acceptance.Support the Show.

Read the full show notes: https://www.draimee.org/pcos-it-has-nothing-to-do-with-cysts Do you know what I think of PCOS? I think the name should really be “Please Confirm this Ovary Syndrome.” I'm telling you, I find that there's no condition that's more misdiagnosed than PCOS.   Today on The Egg Whisperer Show podcast, I'm talking about PCOS, or Polycystic Ovary Syndrome. Did you know that celebrities like Jillian Michaels and Posh Spice both have PCOS?    A few PCOS facts: PCOS does not equal infertility.  You may have a harder time getting pregnant if you have PCOS, because you may not be ovulating frequently or regularly. It's difficult only because it's hard to know when you're ovulating. When you do ovulate with PCOS, you are likely to ovulate multiple eggs, making you very fertile! Every time you ovulate, you make a cyst of ovulation.  Ovulating multiple eggs is what creates multiple cysts, which is where you get the name: Poly (multiple) cystic (cystic). Some symptoms may include: hair loss of the scalp, hirsutism (or hair on your body in areas like the chin, upper abdomen, lower abdomen or back), high testosterone levels, high insulin levels, higher estrogen levels, and higher BMI.  You can help manage PCOS by a paleo-like or mediterranean diet, taking birth control pills which can lower testosterone, or other testosterone-lowering drugs, and supplements. Do you have questions about IVF?Click here to join Dr. Aimee for The IVF Class where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Subscribe to my YouTube channel for more fertility tips! Join Egg Whisperer School Subscribe to the newsletter to get updates Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.   Time stamps: 00:00 Introduction 00:31 Misdiagnosis and Confirmation 03:02 Symptoms and Misconceptions 04:22 PCOS and Fertility 05:33 Evolutionary Advantage 06:56 Normal Ovaries vs PCOS Ovaries 08:42 Impact on Body and Health Risks 10:02 Importance of Early Treatment 11:45 Lifestyle and Medication Management 05:28 Supplements and Natural Remedies 15:22 Comprehensive Management 15:53 Conclusion

According to WHO, the global cost associated with medication errors is 42 billion US dollars. Errors can happen at the point of prescribing, transcribing from one system to the other, or administration, when the wrong patient is given either the wrong drug or the wrong dose. Medication administration errors can be prevented with the introduction of closed-loop medication management, where all points of medication handling are connected and done electronically; even medication administration is done with the help of barcode scanning of the patient barcode and medication barcode. Three European specialists from the Netherlands, UK, and Belgium recently started a European project, Asclepius, which advocated for the introduction of closed-loop medication management systems in the hospitals. They connected with colleagues from UK, France, Iceland, Belgium, Norway, Netherlands, Sweden to strive for alignment on the European level. So in today's discussion, you will hear from Patrick van Oirschot, Patrick Koch and Francine de Stoppelaar talk about the need for improved medication safety. www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/ Show notes: Main Discussion: [00:01:00] Medication administration errors can be prevented with the introduction of closed-loop medication management, where all points of medication handling are connected electronically. Guest Introductions: [00:04:00] Patrick van Oswalt ("Pat"), a veteran in hospital pharmacy with a focus on digitalization and closed-loop medication management strategies. [00:05:00] Francine de Stoppelaer, a clinical pharmacist with a 25-year career in healthcare leadership, notably involved in building and operating the Cleveland Clinic London. [00:06:00] Patrick, with a background in medical imaging and pharmacy automation, emphasizes the need for digital transformation in hospital pharmacies. Challenges and Solutions: [00:08:00] Discussion on medication safety across Europe, highlighting the significant number of medication errors and associated costs. Specific examples include 19,000 deaths per year in Germany due to medication errors. [00:10:00] Explanation of closed-loop medication management and barcode scanning at the bedside to ensure the right medication reaches the right patient. [00:14:00] Different approaches to medication management in various countries, focusing on the importance of digital and automated processes. Implementation Strategies: [00:16:00] Discussion on where hospitals should start when considering digital transformation for medication safety, highlighting the importance of electronic prescribing and bedside scanning. [00:18:00] The experience of implementing a fully digital hospital at Cleveland Clinic London, including workforce planning and gaining buy-in from healthcare professionals. Project Overview: [00:20:00] Introduction to the Asclepius project and its goals to harmonize medication management workflows across Europe. [00:22:00] Highlighting the need for standardization in medication databases and the varying approaches to medication management across different countries. Impact and Future Directions: [00:24:00] The potential impact of digital and automated medication management on patient safety, efficiency, and sustainability. [00:26:00] Encouraging adoption of best practices and the importance of measuring and monetizing the benefits of closed-loop systems. [00:28:00] Challenges in convincing decision-makers and ensuring effective implementation amidst existing workloads.

If you're a first responder struggling with substance dependence or mental health issues, you can get help for addiction and support for healing at Calusa Recovery (+1 866 939 6292). Visit https://calusarecovery.com for details. Calusa Recovery City: Fort Myers Address: 15611 New Hampshire Ct Website: https://www.calusarecovery.com Phone: +1-866-798-3232 Email: info@calusarecovery.com

Tonya Breaux-Shropshire, PhD, DNP, MPH, FNP, Host-Optimizing Medication Management for Hypertension-Welcome to the Hypertension Resistant to Treatment Podcast! Initially, our goal was to empower individuals to effectively manage their blood pressure with the help of healthcare professionals. However, our focus has evolved to prioritize supporting healthcare providers, particularly new nurse practitioners (NPs), recognizing their crucial role in patient outcomes.  We emphasize the significance of equipping healthcare providers with the necessary tools and knowledge for successful patient guidance. Thank you for joining us on this journey towards improved hypertension management. This podcast offers a mixture of informative and inspirational content.****We want to thank all of our sponsors for their generous support. Click here to support this podcast. Many thanks for tuning in. Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.Royalty-free music: Turn on My Swag 2 Epidemic Sound:****Disclaimer: This podcast is not medical advice. Consult your health care provider.

If you're looking for an inclusive place to treat your OCD symptoms, Calusa Recovery (+1 866 939 6292) offers full service medication management recovery programs and therapies. Visit https://calusarecovery.com for details. Calusa Recovery City: Fort Myers Address: 15611 New Hampshire Ct Website: https://www.calusarecovery.com Phone: +1-866-798-3232 Email: info@calusarecovery.com

Deborah Milito, Pharm. D. Director of Skilled Facility Consultants, Adverse Drug Reaction Coordinator and Joint Commission Performance Improvement Coordinator Dr. Milito is the Director of Clinical and Consultant Services-Skilled Division for Diamond Pharmacy Services. She also serves as the team leader for the Joint Commission's Performance Improvement, Provision of Care, Medication Management, and National Patient Safety Goals initiatives. Dr. Milito is responsible for overseeing the education of the Skilled Consultant Pharmacists in Pennsylvania and Ohio. She has 28 years of acute care experience, 8 years of correctional experience, and 13 years of Long-Term Care (LTC) experience. Darshan Kulkarni PharmD, shares 5 Legal Tips to prepare your pharmacy for sale! Joe Lipari, Director of Product Management for Systech joins Todd Eury on "This Week in Pharmacy" to talk about the sensitive and important topic of DSCSA. The Drug Quality and Security Act is a law that amended the Federal Food, Drug, and Cosmetic Act to grant the Food and Drug Administration more authority to regulate and monitor the manufacturing of compounded drugs. Systech is a provider of track & trace, serialization, and brand protection solutions. We hear about key strategic components to consider now, to avoid penalties later. This podcast covers: Exchanging data with authorized trading partners Leveraging a Verification Router Service (VRS) Utilizing a credentialing service with the VRS Implementing a traceability platform Systech now offers three new service packages in conjunction with its software to help manufacturers understand how to meet the Enhanced Drug Security Requirements: Readiness GAP review, compliance testing and master organizational validation. These services will address endpoint data connections, product registrations, authorized trading partner verifications and record keeping requirements.

Our immune system is very important for fighting infections and cancers. However we have to suppress it in order to prevent rejection of transplanted organs. Today, we will discuss "Immunosuppressants and Kidney Transplants: Understanding Medication Management." In this episode, we'll learn the details of immunosuppressive medications, exploring their vital role in preventing organ rejection after kidney transplantation and the importance of medication management in ensuring transplant success. _ The Kidney Zone Podcast with Dr. Mo Welcome to the Kidney Zone, where we will dive deep into the fascinating world of our body's remarkable filters. Get ready to unlock the secrets of the kidneys and transplantation as we travel through their pathways, uncovering vital tips, insightful knowledge, and practical advice to keep our kidneys healthy. Whether you're a patient with kidney disease, a medical professional, or simply curious about the kidneys, this is the place for you. _ Follow Along on Social Media: Facebook: https://www.facebook.com/Dr.Mo.Page Instagram: https://www.instagram.com/dr.mo.ibrahim/ Twitter: https://twitter.com/drmoibrahim TikTok: https://www.tiktok.com/@dr.mo.ibrahim _ Dr. Mo Ibrahim is an assistant professor of kidney transplantation at the University of Maryland, Baltimore. He completed his clinical transplant nephrology fellowship at Washington University in 2022. Originally from Cairo, he pursued a physician/scientist career, conducting research at Duke University from 2012 to 2019. He has authored 70+ journal articles, given a TEDx talk, and holds 5 patents. Currently finishing his PhD at Erasmus University, he drives international collaborations to advance medical technology and improve medical monitoring. _ DISCLAIMER The content of this episode is intended for informational purposes only and is not to be considered medical advice. The information presented here is not meant to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare professional or your doctor before making any healthcare decisions or starting any treatment regimen. Individual medical situations can vary, and only a licensed healthcare provider can offer personalized advice tailored to your specific needs. The creators of this episode are not responsible for any actions taken based on the information provided herein. Any reliance on the content of this episode is at your own risk. If you have any medical concerns or questions, please seek guidance from a medical professional promptly. Remember that medical knowledge and practices can evolve over time, and new information may become available after the creation of this episode. Therefore, it is essential to stay up-to-date with the latest medical research and consult with your healthcare provider to ensure the best possible care for your health.

Larry Margolis, CEO of PersonalRX, provides medication management for patients and caregivers by delivering personalized dose packs to patients' homes with tracking functionality to inform when drugs are taken. The number of people with comorbidities is increasing, requiring complex regimens and medication reconciliation to ensure patient safety. PersonalRX works with healthcare providers, patients, and caregivers to ensure prescription, supplements, and over-the-counter drugs are used correctly. Larry explains, "Our typical patient profile is somebody, on average, who takes nine medications. We service the market of people with five medications or more, representing roughly 12.9% of the population, about 42 million people." "I think one of the most important tools that we use when we're looking at people who are living longer, have more complex cases and comorbidities, and are taking more medication is looking at the medical reconciliation tools that we've built. And we've spent a lot of time over the last year building and enhancing those tools." "So there is a safety hazard that many patients and caregivers don't realize that presents when you have multiple medications, multiple prescribers, supplements, and all of those kinds of things involved. Medications can negatively interact and can be mixed up by pharmacies and patients." "When we can align all of those things into a singular place, PersonalRX is that kind of pharmacy that has trusted supervision for medication management. Still, it improves patient safety and overall health. As complexity increases, we think it's something that becomes more and more important every day." #PersonalRX #Pharmacy #PrescriptionDrugs #MedicationManagement #MedicationDistribution #MedicationInteractions personalrx.com Download the transcript here

Larry Margolis, CEO of PersonalRX, provides medication management for patients and caregivers by delivering personalized dose packs to patients' homes with tracking functionality to inform when drugs are taken. The number of people with comorbidities is increasing, requiring complex regimens and medication reconciliation to ensure patient safety. PersonalRX works with healthcare providers, patients, and caregivers to ensure prescription, supplements, and over-the-counter drugs are used correctly. Larry explains, "Our typical patient profile is somebody, on average, who takes nine medications. We service the market of people with five medications or more, representing roughly 12.9% of the population, about 42 million people." "I think one of the most important tools that we use when we're looking at people who are living longer, have more complex cases and comorbidities, and are taking more medication is looking at the medical reconciliation tools that we've built. And we've spent a lot of time over the last year building and enhancing those tools." "So there is a safety hazard that many patients and caregivers don't realize that presents when you have multiple medications, multiple prescribers, supplements, and all of those kinds of things involved. Medications can negatively interact and can be mixed up by pharmacies and patients." "When we can align all of those things into a singular place, PersonalRX is that kind of pharmacy that has trusted supervision for medication management. Still, it improves patient safety and overall health. As complexity increases, we think it's something that becomes more and more important every day." #PersonalRX #Pharmacy #PrescriptionDrugs #MedicationManagement #MedicationDistribution #MedicationInteractions personalrx.com Listen to the podcast here

According to the Centers for Disease Control and Prevention, autoimmune diseases are the third most common category of diseases in the United States after heart disease and cancer. There are more than 80 different types of autoimmune diseases, making this area of medicine complex and in need of attention from an integrative standpoint. Rheumatology expert Anastasia Stocker, ND, LAc, has expertise in working with patients who are on autoimmune medications. She describes the benefits and risks of medications while exploring integrative approaches that can help with medication tapering or discontinuation when appropriate. About the Expert Anastasia Stocker, ND, LAc, received her doctorate in naturopathic medicine and master of science in acupuncture and Oriental medicine at Bastyr University in Seattle, and her bachelor of science in molecular, cellular, and developmental biology at the University of California, Santa Cruz. This multidisciplinary academic career forged her health philosophy: Healing should be an integration of evidence-based science and traditional natural medicine. Stocker practices at Aria Integrative Medicine in Seattle, with a focus on autoimmune diseases, digestive wellness, environmental medicine, and women's health. She is also the vice president of the Gastroenterology Association of Naturopathic Physicians. Stocker is interested in autoimmune diseases and using her clinical experience in managing complex cases while utilizing integrative approaches. She is passionate about intersecting naturopathic medicine with acupuncture, Chinese herbal medicine, visceral, and craniosacral therapies to facilitate lasting improvements in patients with acute and chronic disease.

Today on the Move to Value Podcast, we continue with part 2 of a presentation on Diabetes Medication Management, given by CHESS Directory of Pharmacy, Rebecca Grandy, who includes helpful information, updates and reminders.

In this episode of the Move to Value Podcast, we continue with our recap of the Move to Value Summit – Nursing Edition which was held on Dec 6. Today we hear part one of the presentation from CHESS Directory of Pharmacy, Rebecca Grandy, who shares information, updates and reminders around Diabetes Medication Management.

In this episode, host Mike Koelzer talks with Charles Gellman, CEO and co-founder of HiDO Health, about the revolutionary integration of AI in pharmacy and home care. Explore how this technology is transforming patient care and medication management. https://us.hidohealth.com/ [00:00:12] - Introduction to Charles Gellman and HiDO Health [00:05:10] - Evolution of AI in Pharmacy [00:10:22] - Enhancing Home Care with Technology [00:15:30] - Personalizing Medicine through AI [00:20:55] - The Role of AI in Home Care [00:25:17] - Shifting Healthcare from Hospitals to Homes [00:30:42] - Innovations in Medication Management and Safety [00:35:25] - Future Vision: Pharmacy's Transformation through AI [00:40:33] - Addressing Medication Compliance with AI Tools [00:45:46] - Closing Discussion: The Broader Impact on Healthcare The Business of Pharmacy Podcast™ offers in-depth, candid conversations with pharmacy business leaders. Hosted by pharmacist Mike Koelzer, each episode covers new topics relevant to pharmacists and pharmacy owners. Listen to a new episode every Monday morning.

We are thrilled to welcome Dr. Kiberd to our podcast. She is not just a dedicated chiropractor, movement specialist, and strength enthusiast; she is a true inspiration. Driven by her own remarkable journey of reversing Hashimoto's, she has developed an unwavering passion for helping women facing the same condition. Her mission is to empower every woman with Hashimoto's to feel strong and confident in her body. Dr. Kiberd excels in teaching women how to exercise effectively, achieve their weight goals, and conquer fatigue. Her expertise allows them to prioritize their well-being and be at their best for their loved ones. Loved having Dr. Kiberd! Topics: 1. Identifying and Managing Food Sensitivities - Importance for Hashimoto's Patients 2. Evolution of Diet Strategies - Transition from Protein Shakes to Paleo 3. Low Histamine Diet - Relevance in Hashimoto's Management 4. Medication Management for Hashimoto's - Guidelines and Considerations 5. Comprehensive Testing - Gut Health Assessment - Parasite Testing - Bloodwork for Thyroid Hormones - Toxin Testing - Organic Acids Test 6. Prevalence of Mold and Parasites - Current Statistics 7. Exercise Focus: Muscle Maintenance and Growth 8. Tracking Progress in Hashimoto's Management - Recommended Monitoring Methods - Symptom Tracking Thanks for tuning in! Get Chloe's Book Today! "⁠⁠⁠⁠⁠⁠75 Gut-Healing Strategies & Biohacks⁠⁠⁠⁠⁠⁠" If you liked this episode, please leave a rating and review or share it to your stories over on Instagram. If you tag @synthesisofwellness, Chloe would love to personally thank you for listening! Follow Chloe on Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@synthesisofwellness⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Chloe on TikTok @chloe_c_porter Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠synthesisofwellness.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to purchase products, subscribe to our mailing list, and more! Or visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠linktr.ee/synthesisofwellness⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to see all of Chloe's links, schedule a BioPhotonic Scanner consult with Chloe, or support the show! Thanks again for tuning in! --- Support this podcast: https://podcasters.spotify.com/pod/show/chloe-porter6/support

Are you using a pill organizer to take your medications? It's time for a health upgrade! Discover the groundbreaking HIDO device created by Charles Gellman, revolutionizing medication management for better health outcomes, whether you are a patient who wants to take care of yourself or a healthcare professional who wants to serve your patients better. This episode will guide you on improving your health and making your life happier!In this episode, you will be able to:Learn how HiDO streamlines the medication dispensing of patients at home.Hear how Charles Gellman changed the future of better health care.Discover how to build a core foundation of a business that serves people.Full Show Notes Here!Links & Mentioned ResourcesHiDO HealthHiDO on LinkedInConnect with Charles GellmanLinkedInFacebookDid you enjoy today's episode? 1. DM me @mrdarrellevans on Instagram.2. Click here to leave us a rating and review on follow on Apple Podcasts.3. Join the weekly MindShift Entrepreneur Newsletter 4. Want help scaling your business? Apply to work with DarrellThanks for listening,Darrell

Join Dr. Holmes and Dr. Fisher as they discuss Dr. Fisher's model of medication for working with the spectrum population. Basics on types of medications and their functions are discussed as well as the dangers of stacking meds and drug-drug interactions often missed. Dr. Fisher completed his General Psychiatry residency at the University of Texas-Galveston and a Child/Adolescent Psychiatry Fellowship at the University of South Carolina. He serves as the Medical leader of Springbrook Autism's Residential and Outpatient Treatment Program (specializing in treating Autism Spectrum Disorders) and is an authority in the minimal medical management of ASD and ASD with comorbidities. Dr. Fisher speaks at Autism Conferences on Medical Overview of Autism Spectrum Disorders, Medication Management for Autism Spectrum Disorders, Myths and Misconceptions in Autism, Autism and Co-Morbid Conditions, and Helping Siblings and other Children Understand Autism.

More than 46 million people in the US met diagnostic criteria for a substance use disorder (SUD) in 2021. These numbers are staggering and suggest that SUD is more common than diabetes in the United States.  However, only 6% received treatment.  Expanding the care delivery model is essential to improving treatment access and enhancing physical, mental, and social/societal outcomes.  Pharmacists can play a key role. Guest Authors: Melissa C. Palmer, PharmD, BCPS, BCPP and Amanda Stahnke, PharmD, BCACP Music by Good Talk

Welcome to "Shit Talking Shrinks" - where two licensed therapists who have invested way too much money in degrees, certifications, and trainings share their love for their profession and sprinkle humor along the way!In this episode, we sit down with the incredible Sam Silverman, a psychiatrist and comedian, for an enlightening discussion that will challenge everything you thought you knew about psychiatric meds and mental health.If you've ever found yourself wondering how to navigate the medication process or how to break free from the stigma surrounding meds, this episode is an absolute game-changer. We're here to empower you, to give you the tools and knowledge you need to take control of your mental health journey like never before.Join us now as we demystify the medication process, taking a no-nonsense approach to address its clinical appropriateness and necessity. But that's not all - we're tackling those harmful misconceptions head-on. Say goodbye to the belief that taking meds means you're "crazy" or that they're only for "severe cases." It's time to reshape the narrative, armed with evidence-backed insights that will blow your mind.Listen now for practical strategies to navigate the psychiatric meds system like a pro. We're giving you the tools to address stigma head-on, to have those conversations that are so desperately needed. It's time to make informed decisions about your mental health, to embrace the importance of meds, and to prioritize your own well-being like never before.Don't miss out on this transformative episode that will leave you feeling empowered and ready to conquer the world. Tune in now and get ready to embrace the power of meds on your journey to mental well-being. This is an episode you won't want to miss!Learn more about Sam Silverman here: https://silvermancomedy.com/Connect with Sam on Instagram here: @samsilvermancomedy#MentalHealthMatters #PsychiatricMedication #TherapyJourney #MentalWellness #BreakTheStigma #MedicationManagement #MentalHealthSupport #TherapyWorks #MentalHealthAwareness #SelfCareRevolutionIf you want to work with me therapeutically and live in CO or ILhttps://www.courageouspathscounseling.comNeed quality therapy ASAP?! Receive 10% off your first month by clicking this link

Hyperemesis Gravidarum (HG) is a potentially life-threatening pregnancy disease that may cause weight loss, malnutrition, dehydration, and debility due to severe nausea and/or vomiting, and may cause long-term health issues for mother and baby(ies). It occurs in up to 3% of pregnant women and may last the entire pregnancy, which can lead to malnourished. Dr. Danielle Plummer has unfortunately been a three-time survivor of HG and she is the founder and CEO of HG clinical solutions (www.hgclinicalsolutions.com). Please visit that website and learn more. She offers personalized medication planning and patient advocacy in addition to educating providers on HG disease state. She has women around the world reaching out to her for advice and support, and she is looking forward to the day that PGx is utilized in all the countries that she is supporting. www.HGPharmacist.com is a link to Danielle's free ebook called "Dear ER doctor, Believe Us" There is also a FaceBook support group: www.facebook.com/groups/hgsolutions. "Coming Soon" is the course called "Preparing for a Hyperemesis Pregnancy". Connect with Danielle to sign up.